Barclays PLC Landec Corp \Ca\ Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Barclays PLC holds 29,944 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,944

Previous 29,944 -0.0%

Holding current value

Previous $147,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	N/A	22,489 Added 301.66%	29,944 $147,000
Q2 2024 Aug 14, 2024	BUY	N/A	7,455 New	7,455 $39,000
Q4 2023 Feb 15, 2024	SELL	N/A	-11,403 Reduced 36.89%	19,508 $121,000
Q3 2023 Nov 07, 2023	BUY	N/A	21,946 Added 244.8%	30,911 $233,000
Q2 2023 Aug 03, 2023	BUY	N/A	8,917 Added 18577.08%	8,965 $87,000
Q1 2023 May 04, 2023	SELL	N/A	-8,136 Reduced 99.41%	48 $0
Q4 2022 Feb 13, 2023	BUY	$0.0 - $9.95 $0 - $69,570	6,992 Added 586.58%	8,184 $53,000
Q3 2022 Nov 03, 2022	SELL	$8.57 - $11.57 $1,036 - $1,399	-121 Reduced 9.22%	1,192 $11,000
Q2 2022 Aug 12, 2022	SELL	$8.84 - $11.64 $25,927 - $34,140	-2,933 Reduced 69.08%	1,313 $13,000
Q1 2022 May 16, 2022	SELL	$10.07 - $11.93 $286,843 - $339,826	-28,485 Reduced 87.03%	4,246 $49,000
Q4 2021 Feb 14, 2022	BUY	$7.95 - $11.24 $167,387 - $236,658	21,055 Added 180.33%	32,731 $363,000
Q3 2021 Nov 09, 2021	SELL	$9.22 - $12.44 $39,756 - $53,641	-4,312 Reduced 26.97%	11,676 $108,000
Q2 2021 Aug 13, 2021	SELL	$9.91 - $12.78 $181,343 - $233,861	-18,299 Reduced 53.37%	15,988 $180,000
Q1 2021 May 13, 2021	BUY	$10.44 - $12.22 $204,770 - $239,683	19,614 Added 133.67%	34,287 $363,000
Q4 2020 Feb 11, 2021	BUY	$9.3 - $11.77 $26,821 - $33,944	2,884 Added 24.46%	14,673 $159,000
Q3 2020 Nov 12, 2020	SELL	$7.59 - $10.8 $18,405 - $26,190	-2,425 Reduced 17.06%	11,789 $115,000
Q2 2020 Aug 12, 2020	SELL	$7.96 - $11.54 $11,072 - $16,052	-1,391 Reduced 8.91%	14,214 $113,000
Q1 2020 May 13, 2020	SELL	$7.69 - $11.68 $82,913 - $125,933	-10,782 Reduced 40.86%	15,605 $135,000
Q4 2019 Feb 10, 2020	BUY	$9.09 - $11.89 $126,105 - $164,949	13,873 Added 110.86%	26,387 $299,000
Q3 2019 Nov 14, 2019	SELL	$9.66 - $12.36 $36,205 - $46,325	-3,748 Reduced 23.05%	12,514 $137,000
Q2 2019 Aug 14, 2019	BUY	$9.32 - $12.98 $81,820 - $113,951	8,779 Added 117.32%	16,262 $153,000
Q1 2019 May 15, 2019	BUY	$10.35 - $13.06 $67,523 - $85,203	6,524 Added 680.29%	7,483 $92,000
Q4 2018 Feb 14, 2019	SELL	$11.64 - $15.41 $124,396 - $164,686	-10,687 Reduced 91.77%	959 $11,000
Q3 2018 Nov 14, 2018	BUY	$12.65 - $15.15 $116,633 - $139,683	9,220 Added 380.05%	11,646 $168,000
Q2 2018 Aug 14, 2018	SELL	$13.05 - $15.45 $44,461 - $52,638	-3,407 Reduced 58.41%	2,426 $37,000
Q1 2018 May 15, 2018	BUY	$12.0 - $14.45 $16,800 - $20,230	1,400 Added 31.58%	5,833 $76,000
Q4 2017 Feb 14, 2018	BUY	$11.65 - $13.35 $35,078 - $40,196	3,011 Added 211.74%	4,433 $56,000
Q3 2017 Nov 14, 2017	BUY	$11.95 - $13.35 $16,992 - $18,983	1,422	1,422 $18,000

Others Institutions Holding LNDC

# of Institutions

Shares Held

20.4M

Call Options Held

65.8K

Put Options Held

14.1K

View Full List

About LANDEC CORP \CA\

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

More about LNDC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account